Biodesix, Inc.
BDSX
$24.00
$0.210.88%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -27.76M | -31.96M | -35.27M | -39.54M | -41.08M |
| Total Depreciation and Amortization | 5.62M | 5.65M | 5.67M | 5.73M | 5.82M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.66M | 5.69M | 5.99M | 6.51M | 6.90M |
| Change in Net Operating Assets | -3.34M | -4.21M | 334.00K | -852.00K | -1.58M |
| Cash from Operations | -19.83M | -24.84M | -23.27M | -28.15M | -29.94M |
| Capital Expenditure | -412.00K | -266.00K | -259.00K | -1.01M | -1.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -157.00K | -144.00K | -144.00K | -171.00K | -207.00K |
| Cash from Investing | -569.00K | -410.00K | -403.00K | -1.18M | -1.40M |
| Total Debt Issued | 0.00 | 10.00M | 10.00M | 10.00M | 10.00M |
| Total Debt Repaid | -15.00K | -19.00K | -21.00K | -29.00K | -38.00K |
| Issuance of Common Stock | 31.75M | 25.07M | 7.82M | 5.50M | 674.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.07M | -1.84M | -1.38M | -948.00K | -787.00K |
| Cash from Financing | 29.67M | 33.22M | 16.42M | 14.53M | 9.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.27M | 7.97M | -7.26M | -14.80M | -21.49M |